Biological approaches to generating cardiac biopacemaker for bradycardia

( views:126, downloads:0 )
Author:
Yong-Fu XIAO(Yong-Fu XIAO,Corresponding author. Tel: + 1-763-5144256; Fax: + 1-763-5143911; E-mail: yong-fu.xiao@medtronic.com)
Daniel C. Sigg()
Journal Title:
ACTA PHYSIOLOGICA SINICA
Issue:
Volume 59, Issue 05, 2007
DOI:
Key Word:
sinoatrial node; biological pacemaker; gene; stem cell; hyperpolarization-activated cyclic-nucleotide-modulated channel

Abstract: Normal rhythm in a healthy human heart originates from the natural biological pacemaker, the sinoatrial (SA) node which locates in the right atrium. SA node dysfunction or atrial-ventricular (AV) conduction block causes improper heart rate (bradycardia).Such dysfunction, if severe enough, is currently treated by implanting an electronic pacemaker which has been well established technically, but there are some limitations and inadequacies. Recently, progress in developing engineered cardiac biopacemakers with use of genes or cells has been made in experimental animal models. The hyperpolarization-activated cyclic-nucleotide-modulated(HCN) channel (pacemaker channel) modulates cardiac automaticity via the hyperpolarization-activated cation current (If). HCN genes have been delivered to animal myocardium via viral vectors or HCN-transferred cells for recreating biological pacemakers. Approaches with non-HCN genes or transplantation of beating cells are also novel and have been investigated for generating cardiac biopacers. This article summarizes the progresses in research on recreation of cardiac biopacemakers. Genetically engineered biological pacemaker holds great promise to potentially cure severe bradycardia if critical issues, such as their stability and longevity, are properly solved.

  • [1]Hauser RG,Hayes DL,Kallinen LM,Cannom DS,Epstein AE,Almquist AK,Song SL,Tyers GF,Vlay SC,Irwin M.Clinical experience with pacemaker pulse generators and transvenous leads:an 8-year prospective multicenter study.Heart Rhythm 2007; 4:154-160.
  • [2]Senaratne J,Irwin ME,Senaratne MP.Pacemaker longevity:are we getting what we are promised? Pacing Clin Electrophysiol 2006; 29:1044-1054.
  • [3]Friedman RA,Fenrich AL,Kertesz NJ.Congenital complete atrioventricular block.Pacing Clin Electrophysiol 2001; 24:1681-1688.
  • [4]Kay GN,Brinker JA,Kawanishi DT,Love CJ,Lloyd MA,Reeves RC,Pioger G,Fee JA,Overland MK,Ensign LG,Grunkemeier GL.Risks of spontaneous injury and extraction of an active fixation pacemaker lead:report of the Accufix Multicenter Clinical Study and Worldwide Registry.Circulation 1999; 100:2344-2352.
  • [5]Miake J,Marban E,Nuss HB.Biological pacemaker created by gene transfer.Nature 2002; 419:132-133.
  • [6]Rosen MR,Brink PR,Cohen IS,Robinson RB.Genes,stem cells and biological pacemakers.Cardiovasc Res 2004; 64:12-23.
  • [7]Marban E,Cho HC.Creation of a biological pacemaker by geneor cell-based approaches.Med Biol Eng Comput 2007; 45:133-144.
  • [8]Plotnikov AN,Sosunov EA,Qu J,Shlapakova IN,Anyukhovsky EP,Liu L,Janse MJ,Brink PR,Cohen IS,Robinson RB,Danilo P Jr,Rosen MR.Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates.Circulation 2004; 109:506-512.
  • [9]Potapova I,Plotnikov A,Lu Z,Danilo P Jr,Valiunas V,Qu J,Doronin S,Zuckerman J,Shlapakova IN,Gao J,Pan Z,Herron AJ,Robinson RB,Brink PR,Rosen MR,Cohen IS.Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers.Circ Res 2004; 94:952-959.
  • [10]Gepstein L.Stem cells as biological heart pacemakers.Expert Opin Biol Ther 2005; 5:1531-1537.
  • [11]Ruhparwar A,Haverich A.Prospects for biological cardiac pacemaker systems.Pacing Clin Electrophysiol 2003; 26:2069-2071.
  • [12]Lin G,Cai J,Jiang H,Shen H,Jiang X,Yu Q,Song J.Biological pacemaker created by fetal cardiomyocyte transplantation.J Biomed Sci 2005; 12:513-519.
  • [13]Cai J,Lin G,Jiang H,Yang B,Jiang X,Yu Q,Song J.Transplanted neonatal cardiomyocytes as a potential biological pacemaker in pigs with complete atrioventricular block.Transplantation 2006; 81:1022-1026.
  • [14]Rosen MR,Robinson RB,Brink P,Cohen IS.Recreating the biological pacemaker.Anat Rec A Discov Mol Cell Evol Biol 2004; 280:1046-1052.
  • [15]Brown HF,DiFrancesco D,Noble SJ.How does adrenaline accelerate the heart? Nature 1979; 280:235-236.
  • [16]Brown H,Difrancesco D.Voltage-clamp investigations of membrane currents underlying pace-maker activity in rabbit sino-atrial node.J Physiol 1980; 308:331-351.
  • [17]DiFrancesco D.A study of the ionic nature of the pace-maker current in calf Purkinje fibres.J Physiol 1981; 314:377-393.
  • [18]DiFrancesco D.A new interpretation of the pace-maker current in calf Purkinje fibres.J Physiol 1981; 314:359-376.
  • [19]Yanagihara K.Ionic current and pacemaker activity of the S-A node cells.Jpn Circ J 1980; 44:531-538.
  • [20]DiFrancesco D,Tortora P.Direct activation of cardiac pacemaker channels by intracellular cyclic AMP.Nature 1991; 351:145-147.
  • [21]Pape HC,McCormick DA.Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current.Nature 1989; 340:715-718.
  • [22]McCormick DA,Pape HC.Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurones.J Physiol 1990; 431:319-342.
  • [23]Viswanathan PC,Coles JA Jr,Sharma V,Sigg DC.Recreating an artificial biological pacemaker:insights from a theoretical model.Heart Rhythm 2006; 3:824-831.
  • [24]Gauss R,Seifert R,Kaupp UB.Molecular identification of a hyperpolarization-activated channel in sea urchin sperm.Nature 1998; 393:583-587.
  • [25]Ludwig A,Zong X,Jeglitsch M,Hofmann F,Biel M.A family of hyperpolarization-activated mammalian cation channels.Nature 1998; 393:587-591.
  • [26]Santoro B,Liu DT,Yao H,Bartsch D,Kandel ER,Siegelbaum SA,Tibbs GR.Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain.Cell 1998; 93:717-729.
  • [27]Pape HC.Queer current and pacemaker:the hyperpolarizationactivated cation current in neurons.Annu Rev Physiol 1996; 58:299-327.
  • [28]Xiao YF,Sigg DC,Leaf A.The antiarrhythmic effect of n-3 polyunsaturated fatty acids:modulation of cardiac ion channels as a potential mechanism.J Membr Biol 2005; 206:141-154.
  • [29]Michels G,Er F,Khan I,Sudkamp M,Herzig S,Hoppe UC.Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias.Circulation 2005; 111:399-404.
  • [30]Stieber J,Stockl G,Herrmann S,Hassfurth B,Hofmann F.Functional expression of the human HCN3 channel.J Biol Chem 2005; 280:34635-34643.
  • [31]Xiao YF,TenBroek EM,Wilhelm JJ,Iaizzo PA,Sigg DC.Electrophysiological characterization of murine HL-5 atrial cardiomyocytes.Am J Physiol Cell Physiol 2006; 291:C407-C416.
  • [32]Robinson RB,Siegelbaum SA.Hyperpolarization-activated cation currents:from molecules to physiological function.Annu Rev Physiol 2003; 65:453-480.
  • [33]Thollon C,Bedut S,Villeneuve N,Coge F,Piffard L,Guillaumin JP,Brunel-Jacquemin C,Chomarat P,Boutin JA,Peglion JL,Vilaine JP.Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity.Br J Pharmacol 2007; 150:37-46.
  • [34]Robinson RB,Yu H,Chang F,Cohen IS.Developmental change in the voltage-dependence of the pacemaker current,If,in rat ventricle cells.Pflugers Arch 1997; 433:533-535.
  • [35]Azene EM,Xue T,Marban E,Tomaselli GF,Li RA.Nonequilibrium behavior of HCN channels:insights into the role of HCN channels in native and engineered pacemakers.Cardiovasc Res 2005; 67:263-273.
  • [36]Mannikko R,Pandey S,Larsson HP,Elinder F.Hysteresis in the voltage dependence of HCN channels:conversion between two modes affects pacemaker properties.J Gen Physiol 2005;125:305-326.
  • [37]Elinder F,Mannikko R,Pandey S,Larsson HP.Mode shifts in the voltage gating of the mouse and human HCN2 and HCN4 channels.J Physiol 2006; 575:417-431.
  • [38]Sarachek NS,Leonard JL.Familial heart block and sinus bradycardia.Classification and natural history.Am J Cardiol 1972; 29:451-458.
  • [39]Schulze-Bahr E,Neu A,Friederich P,Kaupp UB,Breithardt G,Pongs O,Isbrandt D.Pacemaker channel dysfunction in a patient with sinus node disease.J Clin Invest 2003; 111:1537-1545.
  • [40]Ueda K,Nakamura K,Hayashi T,Inagaki N,Takahashi M,Arimura T,Morita H,Higashiuesato Y,Hirano Y,Yasunami M,Takishita S,Yamashina A,Ohe T,Sunamori M,Hiraoka M,Kimura A.Functional characterization of a trafficking-defective HCN4 mutation,D553N,associated with cardiac arrhythmia.J Biol Chem 2004; 279:27194-27198.
  • [41]Milanesi R,Baruscotti M,Gnecchi-Ruscone T,DiFrancesco D.Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel.N Engl J Med 2006; 354:151-157.
  • [42]Qu J,Plotnikov AN,Danilo P Jr,Shlapakova I,Cohen IS,Robinson RB,Rosen MR.Expression and function of a biological pacemaker in canine heart.Circulation 2003; 107:1106-1109.
  • [43]Tse HF,Xue T,Lau CP,Siu CW,Wang K,Zhang QY,Tomaselli GF,Akar FG,Li RA.Bioartificial sinus node constructed via in vivo gene transfer of an engineered pacemaker HCN channel reduces the dependence on electronic pacemaker in a sick-sinus syndrome model.Circulation 2006; 114:1000-1011.
  • [44]Zhong YM (钟幼民),Guo JH,Zhang P,Li JW,Liu YW,Zhou CY,Zhang YY.Transfecting rat heart with human pacemaker gene in vivo to create a biological pacemaker.Chin Med J (中华医学杂志) 2006; 86:2831-2835 (Chinese,English abstract).
  • [45]Cai J,Yi FF,Li YH,Yang XC,Song J,Jiang XJ,Jiang H,Lin GS,Wang W.Adenoviral gene transfer of HCN4 creates a genetic pacemaker in pigs with complete atrioventricular block.Life Sci 2007; 80:1746-1753.
  • [46]Bucchi A,Plotnikov AN,Shlapakova I,Danilo P Jr,Kryukova Y,Qu J,Lu Z,Liu H,Pan,Z,Potapova I,KenKnight B,Girouard S,Cohen IS,Brink PR,Robinson RB,Rosen MR.Wild-type and mutant HCN channels in a tandem biological-electronic cardiac pacemaker.Circulation 2006; 114:992-999.
  • [47]Xue T,Siu CW,Lieu DK,Lau CP,Tse HF,Li RA.Mechanistic role of If revealed by induction of ventricular automaticity by somatic gene transfer of gating-engineered pacemaker (HCN)channels.Circulation 2007; 115:1839-1850.
  • [48]Edelberg JM,Huang DT,Josephson ME,Rosenberg RD.Molecular enhancement of porcine cardiac chronotropy.Heart 2001;86:559-562.
  • [49]Edelberg JM,Aird WC,Rosenberg RD.Enhancement of murine cardiac chronotropy by the molecular transfer of the human β2 adrenergic receptor cDNA.J Clin Invest 1998; 101:337-343.
  • [50]Brendel J,Peukert S.Blockers of the Kv1.5 channel for thetreatment of atrial arrhythmias.Curr Med Chem Cardiovasc Hematol Agents 2003; 1:273-287.
  • [51]Kurata Y,Hisatome I,Matsuda H,aShibamoto T.Dynamical mechanisms of pacemaker generation in IK1-downregulated human ventricular myocytes:insights from bifurcation analyses of a mathematical model.Biophys J 2005; 89:2865-2887.
  • [52]Kashiwakura Y,Cho HC,Barth AS,Azene E,Marban E.Gene transfer of a synthetic pacemaker channel into the heart:a novel strategy for biological pacing.Circulation 2006; 114:1682-1686.
  • [53]Ruhparwar A,Tebbenjohanns J,Niehaus M,Mengel M,Irtel T,Kofidis T,Pichlmaier AM,Haverich A.Transplanted fetal cardiomyocytes as cardiac pacemaker.Eur J Cardiothorac Surg 2002; 21:853-857.
  • [54]Gepstein L.Cardiovascular therapeutic aspects of cell therapy and stem cells.Ann NY Acad Sci 2006; 1080:415-425.
  • [55]Kolossov E,Lu Z,Drobinskaya I,Gassanov N,Duan Y,Sauer H,Manzke O,Bloch W,Bohlen H,Hescheler J,Fleischmann BK.Identification and characterization of embryonic stem cellderived pacemaker and atrial cardiomyocytes.FASEB J 2005; 19:577-579.
  • [56]Maltsev VA,Rohwedel J,Hescheler J,Wobus AM.Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal,atrial and ventricular cell types.Mech Dev 1993; 44:41-50.
  • [57]Kehat I,Khimovich L,Caspi O,Gepstein A,Shofti R,Arbel G,Huber I,Satin J,Itskovitz-Eldor J,Gepstein L.Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.Nat Biotechnol 2004; 22:1282-1289.
  • [58]Xue T,Cho HC,Akar FG,Tsang SY,Jones SP,Marban E,Tomaselli GF,Li RA.Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes:insights into the development of cell-based pacemakers.Circulation 2005; 111:11-20.
  • [59]Sartiani L,Bettiol E,Stillitano F,Mugelli A,Cerbai E,Jaconi ME.Developmental changes in cardiomyocytes differentiated from human embryonic stem cells:a molecular and electrophysiological approach.Stem Cells 2007; 25:1136-1144.
  • [60]Huber I,Itzhaki I,Caspi O,Arbel G,Tzukerman M,Gepstein A,Habib M,Yankelson L,Kehat I,Gepstein L.Identification and selection of cardiomyocytes during human embryonic stem cell differentiation.FASEB J 2007; 21:2551-2563.
  • [61]Schweizer PA,Krause U,Becker R,Seckinger A,Bauer A,Hardt C,Eckstein V,Ho AD,Koenen M,Katus HA,Zehelein J.Atrialradiofrequency catheter ablation mediated targeting of mesenchymal stromal cells.Stem Cells 2007; 25:1546-1551.
  • [62]Cho HC,Kashiwakura Y,Marban E.Creation of a biological pacemaker by cell fusion.Circ Res 2007; 100:1112-1115.
  • [63]Ludwig A,Zong X,Stieber J,Hullin R,Hofmann F,Biel M.Two pacemaker channels from human heart with profoundly different activation kinetics.EMBO J 1999; 18:2323-2329.
  • [64]Stieber J,Herrmann S,Feil S,Loster J,Feil R,Biel M,Hofmann F,Ludwig A.The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.Proc Natl Acad Sci USA 2003; 100:15235-15240.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn